Eiko Lifesciences Ltd

BSE : Eiko_Lifescience14 Jan 2025

Chemicals

₹

-0.52 (-1.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Eiko Lifesciences Ltd

Eiko Lifesciences Ltd

Chemicals

BSE : Eiko_Lifescience14 Jan 2025

₹

-0.52 (-1.00%)

OverviewFundamentals

Corporate action

Peer comparison

Cash flow

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
05-Apr-2017	D	Outcome of Board Meeting held today at the registered office of the company along with Audited Financial Results for the year ended 31st March' 2017. Board is pleased to declare the maiden dividend @2.50% or 25 paise per equity share of face value of Rs. 10/- each.	20-Sep-2017
30-Jun-2023	R	2:3 Right Issue of Equity Shares Trading Members of the Exchange are hereby informed that EIKO LIFESCIENCES LIMITED has fixed Record Date for the purpose of Rights Issue of Equity Shares of the Company. The transactions in the Equity Shares of the Company should be done on Ex-Rights basis with effect from the under mentioned date :- DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE EIKO LIFESCIENCES LIMITED (540204) RECORD DATE 07.07.2023 PURPOSE Issue of 2 (Two) Equity Shares of Rs.10/- each for cash at a premium of Rs.35/- per share on Rights Basis for every 3 (Three) Equity Shares held.* Ex-Right basis from Date & Sett. No. 07/07/2023 DR-566/2023-2024 * Note : As per terms of Payment : Issue Price of Rs.45/- payable as Rs.13.50 per Rights Equity Share (including premium of Rs.10.50) to be paid on Application. Balance to be paid in not more than two calls as determined by our Board at its sole discretion. Trading Members of the Exchange are requested to take note of it. (As Per BSE Notice Dated on 04.07.2023)	07-Jul-2023	2:3
19-Nov-2024	BC	Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/11/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Li	25-Nov-2024
25-Nov-2024	BC	Lenus Finvest Pvt Ltd	18-Nov-2024
11-Oct-2024	BC	Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/10/2024 inter alia to consider and approve The Unaudited Financial Results (Standalo	19-Oct-2024
10-Jul-2024	BC	Swaraj Shares and Securities Pvt. Ltd ('Manager to the Open Offer') has submitted to BSE a copy of Public Announcement under the provisions of Regulations 3(1), read with Regulations 13 (1), 14, and	09-Oct-2024
30-Sep-2024	BC	Announcement under Regulation 30 (LODR)	30-Sep-2024

Record Date01 Jan'1900

Ex-Rights Date01 Jan'1900

Premium(Rs.)35

Ratio2:3

Book Closure

Record Date	Split Date	Purpose
25-Nov-2024	-	Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/11/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Li
18-Nov-2024	-	Lenus Finvest Pvt Ltd
19-Oct-2024	-	Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/10/2024 inter alia to consider and approve The Unaudited Financial Results (Standalo
09-Oct-2024	01 Jan'1900	Swaraj Shares and Securities Pvt. Ltd ('Manager to the Open Offer') has submitted to BSE a copy of Public Announcement under the provisions of Regulations 3(1), read with Regulations 13 (1), 14, and
30-Sep-2024	-	Announcement under Regulation 30 (LODR)

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Eiko Lifesciences Ltd ₹51.35(-0.52/-1.00%)	51.35	-0.52	63.93	-26.55	57.70	1.26
BASF India Ltd ₹4,938.15(+103.75/2.15%)	4,938.15	+103.75	21,375.10	61.58	33.40	6.09
Advance Petrochemicals Ltd ₹215.35(+8.95/4.34%)	215.35	+8.95	19.38	8.95	91.25	5.28
Bhagawati Oxygen Ltd ₹56.69(-2.98/-4.99%)	56.69	-2.98	13.10	-2.02	0.00	3.19
Atul Ltd ₹6,733.45(+118.25/1.79%)	6,733.45	+118.25	19,824.46	-3.66	46.91	3.56
Oriental Aromatics Ltd ₹387.85(+9.40/2.48%)	387.85	+9.40	1,305.25	-8.27	31.95	1.98

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash and Cash Equivalents at Beginning of the year	0.61	0.22	4.07	0.02	0.03
Net Cash from Operating Activities	-7.08	4.22	-7.73	-0.83	0.77
Net Cash Used In Investing Activities	-0.55	0.87	0.59	-2.94	-0.65
Net Cash Used In Financing Activities	20.36	-4.70	3.28	7.81	-0.13
Net Inc./Dec In Cash And Cash Equivalents	12.73	0.40	-3.85	4.05	-0.01
Cash And Cash Equivalents At End Of The Year	13.35	0.61	0.22	4.07	0.02

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

31.27%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

68.73%

**Promoter pledged shareholding 31.27%

About Eiko Lifesciences Ltd

Eiko Lifesciences Ltd is in the Chemicals sector, having a market capitalization of Rs. 63.93 crores. It has reported a sales of Rs. 7.74 crores and a net profit of Rs. 0.21 crores for the quarter ended December 2018. The company management includes Laxmikant Kabra, Laxmikant Kabra,Bhavesh Dhirajlal Tanna,Rajkumar K Baheti,Mandkar Kamalakar Patil,Kajal Dhanpatraj Kothari,Umesh Ravindranath More,Chintan Doshi (Eiko Lifesciences Ltd) among others.

Chairman

Laxmikant Kabra

Registered office

1st Matru Chhaya Ground Floor,M Karve Road Naupada,Thane,Maharashtra,400602

FAX :

Background

Incorporation Year1977

Face Value₹10

Market Lot1